We studied 229 patients with abnormal adrenal anatomy depicted by CT w
ho were without biochemical evidence of endocrine dysfunction using th
e presence of(131)I-6 beta-iodomethyl-norcholesterol (NP-59) adrenal g
land uptake as an index of differential adrenal function in the evalua
tion of the clinically ''silent'' adrenal mass lesion. Methods: NP-59
(1 mCi) was injected intravenously with posterior and lateral abdomina
l images obtained 5-7 days postinjection. Results: One-hundred and fif
ty-nine of 185 patients with unilateral adrenal enlargement on CT had
scintigraphic evidence that the mass represented a functioning (NP-59
avid) but not hypersecretory, (biochemically normal) adrenal cortical
adenoma (concordant imaging pattern). Forty-one of 44 patients with in
tra-adrenal neoplasms were depicted on scintigraphy as decreased or ab
sent NP-59 accumulation on the side of the adrenal mass (discordant im
aging pattern). In this study, sensitivity was 71% (41 of 58 patients;
95% confidence interval (CI), 58% to 88%); specificity was 100% (171
of 171 patients:; 95% CI, 95% to 100%) and accuracy was 93% (212 of 22
9 patients; 95% CI, 88% to 96%). Conclusions: These data confirm our e
arlier observations that the functional information depicted by scinti
graphy complements the morphological evaluation by CT and in the absen
ce of hormonal dysfunction, the presence of concordant CT and I-131-NP
-59 scans are characteristic of functioning, but not hypersecretory, b
enign adrenocortical adenomas. Conversely, discordant CT and I-131-NP-
59 scans are suggestive of nonfunctioning, space-occupying, adrenal le
sions.